… While anti-Tumor Necrosis Factor (TNF)-alfa drugs should be … Regarding tildrakizumab, a
recent multicenter real-life study … you can manage your cookie settings, please see our Cookie …

… a retrospective, multicenter study to assess both the safety and the effectiveness of TNF-alpha
inhibitors and ustekinumab in patients with psoriasis and chronic viral hepatitis B or C [65]. …

… of 28 cases of psoriasis treated with ustekinumab that was … , retrospective study was
performed on 958 patients with … You can change your cookie settings at any time by following …

… Hepatitis B virus reactivation is a well-known event in … , a retrospective analysis of 2148
patients with chronic arthritis or … with ustekinumab for recalcitrant psoriasis and psoriatic arthritis […

… On the one hand, the use of anti-Tumor Necrosis Factor … Hepatitis B is a type of viral
hepatitis caused by the Hepatitis … due to psoriasis severity, the impact on the patient’s quality of …

… Nevertheless, a multicentre study of 46 patients treated with … for ustekinumab also seem to
demonstrate good efficacy and … literature to evaluate the impact of TB, hepatitis B and C, HIV, …

… , inflammatory bowel disease, hepatitis B, nonmelanoma skin … = 546 psoriasis and PsA/747
total PsA), ustekinumab resulted … CD (n = 487) in retrospective observational studies [78, 79]. …

… The most common adverse event was psoriasis or psoriasiform, … hepatitis B core antigen,
anti-hepatitis A virus IgM, and anti-… three patients (the two CD patients switched to ustekinumab, …

… after anti-tumor necrosis factor (anti-TNF) therapy in cases with … in treating psoriasis are lower
than in treating CD, in this study … viral hepatitis B or C: a retrospective, multicentre study in a …

… Biologic therapies, such as antitumour necrosis factor (TNF), … tests (screening for HIV and
hepatitis B and C viruses), the … than ustekinumab in patients with moderate-to-severe plaque …